Irene Altabas-Gonzalez
Las Palmas De Gran Canaria, CN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Update to the Sociedad Española de Reumatología Guidelines on the Use of Biological Therapy in Systemic Lupus Erythematosus.
Journal: Reumatologia clinica
Published: April 18, 2026
Clinical characteristics of patients with antisynthetase syndrome and dermatomyositis-type skin involvement: Insights from the Myo-Spain registry.
Journal: Seminars in arthritis and rheumatism
Published: March 07, 2026
Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry.
Journal: Lupus science & medicine
Published: September 25, 2025
Does adding concomitant immunosuppressive therapy to belimumab provide additional benefits in SLE? Results from the BEL-Spain Registry.
Journal: Rheumatology (Oxford, England)
Published: September 15, 2025
Self-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data.
Journal: BMC rheumatology
Published: September 12, 2025
Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality.
Journal: Lupus science & medicine
Published: August 06, 2025
Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La.
Journal: Lupus
Published: April 01, 2025
Cancer risk in Sjögren's disease: A longitudinal cohort study on incidence, predictors, and mortality impact.
Journal: Seminars in arthritis and rheumatism
Published: March 12, 2025
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.
Journal: Arthritis research & therapy
Published: August 19, 2024
Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?
Journal: Rheumatology (Oxford, England)
Published: January 16, 2024
Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus.
Journal: Arthritis research & therapy
Published: January 11, 2024
Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.
Journal: Lupus science & medicine
Published: October 19, 2023
Last Updated: 09/26/2026